Study compares Single-Incision with standard 4-port Laparoscopic cholecystectomy

Written By :  MD Bureau
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2020-12-15 13:28 GMT   |   Update On 2020-12-15 13:28 GMT
Advertisement

A research team of AIMS, New Delhi have found that the Single-Incision Laparoscopic Cholecystectomy (SILC) is safer with a higher cosmetic score and comparable quality of life (QoL) but with a higher incidence of complication when compared with standard 4-port Laparoscopic cholecystectomy. The study details were published in the Indian Journal of Surgery on 23 January 2020.

Four-port laparoscopic cholecystectomy (LC) is the gold standard treatment for symptomatic gallbladder disease. To reduce the invasiveness of standard four-port laparoscopic cholecystectomy, a single umbilical incision laparoscopic cholecystectomy has come about an attractive option for the performance of laparoscopic cholecystectomy. Laparoscopy through a single umbilical incision is an emerging technique supported by case series, but prospective comparative data are lacking on SILC especially in the Indian subcontinent. For the same purpose, researchers in AIMS conducted a prospective study to compare the outcomes of SILC with the standard four-port LC.

Advertisement

It was a randomized-controlled prospective comparative study in 94 patients with symptomatic cholelithiasis between May 2012 and April 2014. Patients were randomized to either standard four-port laparoscopic cholecystectomy (LC group) or single-incision laparoscopic cholecystectomy (SILC group). Demographic profile, preoperative and intraoperative variables, postoperative complications, hospital stay, and pain scores were recorded. Patients were followed up at regular intervals, and satisfaction scores were recorded. Researchers used WHO-QoL BREF to assess the quality of life.

Key findings of the study were:

Upon analysis, the researchers found demographic profile and preoperative WHO-QoL BREF scores were comparable between the two groups. The severity of adhesions, successful dissection of Calot's triangle, ergonomics, and overall level of difficulty were also found to be comparable.

They noted that the operation time was significantly higher in the SILC group. However, the learning curve was seen to be achieved after 30–35 cases.

They found no significant difference in the incidence of immediate postoperative and chronic pain over a mean follow-up of 6 months.

They also found pain score during normal activity in the immediate postoperative period was significantly higher in the SILC group than in 4 port LC group.

They observed that the complication rate was significantly higher in the SILC group, but the incidence of SSI (Surgical Site Infection) was not found to be significant among the two groups.

Postoperative quality of life outcomes was similar in the two groups.

They noted patients in the SILC group had higher cosmetic score compared with the LC group but it was not found to be significant.

The authors concluded, "this study shows that SILC is safe and feasible with a higher rate of complications but comparable cosmetic and QoL outcomes when compared with standard 4-port cholecystectomy".

For further information:

https://link.springer.com/article/10.1007/s12262-020-02081-6


Tags:    
Article Source :  Indian Journal of Surgery

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News